| |
| |
|
| Insider
Information: |
Link Max |
| Relationship: |
Director |
| City: |
8044 Zurich Switzerland |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
1,228,236 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,500,079 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,228,236 |
|
|
| Total
Value |
$12,500,079 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Juniper Pharmaceuticals Inc |
JNP |
Director |
2003-08-08 |
23,000 |
2003-08-08 |
0 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
Director |
2005-09-30 |
73,572 |
2003-09-25 |
0 |
Premium* |
|
|
Windtree Therapeutics Inc |
WINT |
Director |
2007-03-09 |
166,821 |
2003-09-25 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2005-11-02 |
159,916 |
2003-09-25 |
0 |
Premium* |
|
|
Celsion Corp |
CLSN |
Director |
2012-12-10 |
380,385 |
2003-12-22 |
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2014-02-28 |
59,469 |
2004-04-06 |
0 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2008-04-11 |
27,699 |
2007-07-10 |
0 |
Premium* |
|
|
Ladrx |
LADX |
Director |
2012-02-23 |
260,305 |
2007-04-27 |
0 |
Premium* |
|
|
Sintx Technologies Ord Shs |
SINT |
Director |
2014-08-12 |
77,069 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
69 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLSN |
Celsion Corp |
Director |
– • – |
2003-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
41,287 |
0 |
|
- |
|
| CLSN |
Celsion Corp |
Director |
– • – |
2005-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
98,684 |
620,095 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2005-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
76,072 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
– • – |
2006-01-09 |
4 |
A |
$20.72 |
$41,440 |
D/D |
2,000 |
62,157 |
|
- |
|
| CLSN |
Celsion Corp |
Director |
– • – |
2006-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,127 |
60,800 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
47,577 |
0 |
- |
|
| CLSN |
Celsion Corp |
Director |
– • – |
2007-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,896 |
103,362 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2007-07-10 |
4 |
A |
$8.99 |
$3,749 |
D/D |
417 |
25,417 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2007-10-10 |
4 |
A |
$10.02 |
$4,749 |
D/D |
474 |
25,891 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
84,743 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2008-01-11 |
4 |
A |
$11.62 |
$9,621 |
D/D |
828 |
26,719 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2008-04-11 |
4 |
A |
$6.50 |
$6,370 |
D/D |
980 |
27,699 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2009-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,089 |
174,575 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-02-22 |
4/A |
A |
$0.00 |
$0 |
D/D |
0 |
140,265 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,471 |
98,574 |
0 |
- |
|
| SINT |
Sintx Technologies Ord Sh... |
Director |
– • – |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
57,864 |
70,666 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
59,469 |
0 |
- |
|
| SINT |
Sintx Technologies Ord Sh... |
Director |
– • – |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,984 |
77,069 |
0 |
- |
|
| CLSN |
Celsion Corp |
Director |
– • – |
2003-12-22 |
4 |
B |
$1.09 |
$25,002 |
D/D |
22,938 |
521,411 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2004-04-06 |
4 |
B |
$10.74 |
$169,914 |
D/D |
9,501 |
37,667 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2004-12-29 |
4 |
B |
$15.58 |
$81,575 |
D/D |
5,000 |
42,657 |
2.39 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2005-03-10 |
4 |
B |
$5.20 |
$26,000 |
D/D |
5,000 |
73,572 |
2.39 |
- |
|
| CLSN |
Celsion Corp |
Director |
– • – |
2005-05-23 |
4 |
B |
$0.40 |
$17,742 |
D/D |
44,300 |
664,395 |
2.39 |
- |
|
| CLSN |
Celsion Corp |
Director |
– • – |
2005-05-24 |
4 |
B |
$0.41 |
$23,060 |
D/D |
55,700 |
720,095 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2005-10-10 |
4 |
B |
$26.62 |
$401,562 |
D/D |
15,000 |
57,657 |
2.39 |
- |
|
69 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
